2011 Gastrointestinal Oncology Conference Review |
2011 Gastrointestinal Oncology Conference Please click on abstract title to review abstract PDF file (opens in a new window). |
|
Esophageal Cancer | |
Controversies in Adjuvant and Neoadjuvant Therapy in Gastroesophageal Cancer |
|
Surgery vs. Chemo-radiotherapy plus Surgery in Resectable Esophageal Cancer: A Systematic Review of Randomized Controlled Trials |
|
Pancreatic Cancer | |
Metastatic Pancreatic Cancer: Are We Making Progress? |
|
Should Neoadjuvant Therapy for Pancreatic Cancer Adenocarcinoma be the Standard for All Patients? No! |
|
Molecular Mechanisms of Resistance to STAT3 inhibition in Pancreatic Cancer |
|
Advanced Colorectal Cancer | |
Using Biomarkers to Manage Therapy in Advanced Colorectal Cancer |
|
Identification of MicroRNAs Differentially Expressed in Normal Colon and Colon Cancer Stem Cells |
|
The Association Between Metabolic Syndrome and Colorectal Neoplasm: A Meta-analysis of Epidemiologic Evidence |
|
Hot Topics in Gastrointestinal Oncology | |
The Future of Cooperative Clinical Research in Gastrointestinal Oncology |
|
Advances in CT Imaging of GI Malignancies |
|
S-1 Plus Intravenous and Intraperitoneal Paclitaxel for Gastric Cancer With Peritoneal Metastasis |
|
Reprogrammed Induced-Pluripotent-Stem Cells (iPSCs) Encoded With Anti-GRP78 shRNA Induces Apoptosis After a Gene-Silencing Bystander Effect Circumventing Vinorelbine-Induced Angiogenesis, and Metastatic Spread in Advanced Gastro-Intestinal Stromal Tumors (GIST) |
|
Neuroendocrine Tumors (NET) | |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial (RADIANT-3) of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: Updated Safety and Overall Survival Results |
|
Updated Efficacy, Safety, and Exploratory Biomarker Results From RADIANT-2: A Phase III Trial of Everolimus + Octreotide LAR vs. Placebo + Octreotide LAR in Patients With Advanced Neuroendocrine Tumors |
|
Hepatobiliary Cancer | |
Systemic Therapy for Cholangiocarcinoma |
|
Molecular Profile of Hepatocellular Carcinoma in India with Special Reference to GST gene Polymorphism |
|
POSTER PRESENTATIONS | |
Esophageal/Gastric Cancer | |
Concurrent Radiotherapy and Capecitabine as Adjuvant Treatment after Surgery for Gastric Cancer |
|
Efficacy of Endoscopic Submucosal Dissection for Early Gastric Neoplasms: Analysis of 1123 Lesions |
|
Erlotinib and Radiation Therapy for Elderly Patients With Esophageal Cancer: Clinical and Correlative Results From a Prospective Multicenter Phase II trial |
|
Esophagectomy for Esophageal Cancer: Results of the Last Decade From a Tertiary Care Center of North India |
|
Hyperbaric Oxygen Therapy: An Adjuvant Treatment Modality for Chemo-Radiation Induced Hemorrhagic Gastritis |
|
Topography of Chronic Active Gastritis Among Helicobacter Pylori Positive Patients in Bangladesh |
|
Pancreatic Cancer | |
Comparison of Efficacy Between Gemcitabine/Erlotinib (GE) and Gemcitabine/Capecitabine (GX) in Unresectable Pancreatic Cancer: Retrospective, Single Center Experience, Final Report |
|
Etiology of Enlarged Heart: A Rare Pancreatic Tumor |
|
Genetic Alterations of Pancreatic Cancer In North Indian Population |
|
LNA-Modified Oligonucleotides Targeting mRNA of DICER in Pegylated Colloidal Nanoparticles With Linked Αbs Against CD44 on Pancreatic Cancer Stem Cells (PCSCs) Induces PCD After Inhibition Of Oncomirs Leading to Downregulation of Antiapoptotic Oncogenes That Interact With Their 3'UTRs and Inhibition of DNA Hypermethylation Leading to Activation of Apoptotic Tumor Suppressor Genes |
|
Colorectal Cancer | |
A Retrospective Single Study Analysis of Survival Outcomes in Metastatic Colorectal Cancer |
|
Response To Systemic Chemotherapy With Cetuximab in KRAS Mutated Patients With Liver Metastases From Colorectal Cancer |
|
Single Incision Laparoscopic Right Hemicolectomy in Advanced Colon Cancer |
|
The Association between Helicobacter pylori infection and Colorectal Cancer: A Meta-Analysis of Epidemiologic Evidence |
|
A Superficial Colon Tumor Model Involving Subcutaneous Colon Translocation and Orthotopic Transplantation of Green fluorescent Protein-Expressing Human Colon Tumor |
|
Expression and Clinical Significance of Notch Signaling Genes in Colorectal Cancer |
|
Pilot Study of Short-Course Preoperative Radiation Therapy using Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer |
|
Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases |
|
Neuroendocrine Tumors (NET) | |
Temozolomide and Thalidomide for Neuroendocrine Tumors: A Retrospective Report |
|
Hepatobiliary Cancer | |
Eradication of Unresectable Chemo/Radioresistant Hilar Cholangiocarcinoma With Gene-Modified Cellular Vaccine (GMCV) Composed of Autologous Adipose-Derived Mesenchymal Stem Cells (AADMSCs) Transfected With Lipid-cation Hsp70 Activated Innate and Adaptive Immunity, and Induced SecondaryNecrosis Leading to a Lethal Bystander Effect |
|
Human APEndonuclease (APE1/ref-1), a DNA Repair Enzyme, in Gall Bladder Cancer and its Correlation With Tumor Infiltration and Perineural Invasion |
|
Phase I Adjuvant Trial of Sorafenib in Hepatocellular Carcinoma (HCC) Patients After Orthotopic Liver Transplantation (OLT) |
|
ABSTRACTS SELECTED FOR ORAL PRESENTATION | |
Hot Topics | |
HER2 Status in Gastric and Gastroesophageal Junction Adenocarcinoma: Analysis of 726 Consecutive Cases in Four Chinese Hospitals |
|
Localized/Adjuvant Colorectal Cancer | |
Lymph Node Correlations and Thresholds in Colorectal Cancer Specimens |
|
©2022 International Society of Gastrointestinal Oncology | info@isgio.org |